A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa

Summary

The main purpose of this study is to evaluate the effect of LAD328 compared to placebo in participants with moderate-to-severe Hidradenitis Suppurativa (HS), and to access the safety, tolerability, pharmacokinetic and immunogenicity in participants with moderate-to-severe HS.

Timeline

Start

2026-04

Primary completion

2027-02

Completion

2027-04

Drugs

Indications